There is a sharp decline in the use of inferior vena cava (IVC) filter placement and retrieval procedures over the last decade, a research team at the Harvey L. Neiman Health Policy Institute Finds.

Wide variation exists in the use of inferior vena cava filters for the treatment of venous thromboembolism, possibly because of a deficit of evidence on the efficacy of these devices, and a lack of ...

More than one-third of patients undergoing catheter-directed thrombolysis of deep vein thrombosis receive an inferior vena cava (IVC) filter, yet placement of the device is not associated with a ...

Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava filters -- devices used to keep blood clots from ...

WASHINGTON -- The same year that the FDA warned against long-term use of inferior vena cava (IVC) filters, placement rates took a downward turn, researchers said. Separately, one center reported ...

The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...

Optional vena cava filters can used to provide either short-term or permanent protection from pulmonary embolism. These devices have recently become available for clinical use in the United States.

Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...

Effect of tolfenamic acid on ovarian cancer cell growth, targeting of specificity protein transcription factors, and expression of c-Met and survivin. Background: Venous thrombosis is a frequent ...

Please provide your email address to receive an email when new articles are posted on . Inferior vena cava filters have become an increasingly popular tool to reduce risk for recurrent pulmonary ...